Search
06/02/2026
Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain
Micó, M, Trapé, J, González-García, L, Trujillo-Isern, G, González-Fernández, C, López-Madueño, J, Bérgamo, S, Pérez-Vidal, R, Flor, A, Martínez-Montero, R, Rives, J, Arnau, A, Fàbrega, A. Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain. BMC INFECTIOUS DISEASES. 2026; 26(1)DOI:10.1186/s12879-026-12796-8. PMID:41652586. IF:3.000(Q2/4D).
06/02/2026
Immune-mediated protection and enhancement of dengue drives patterns of infant cases in Brazil
Hitchings, MDT, Huang, AT, Ranzani, OT, García-Carreras, B, Nogueira, ML, Ko, AI, Croda, J, Salje, H, Cummings, DAT. Immune-mediated protection and enhancement of dengue drives patterns of infant cases in Brazil. Nature Communications. 2026; 17(1)DOI:10.1038/s41467-026-69111-x. PMID:41651817. IF:15.700(Q1/1D).
04/02/2026
Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome
Morcillo-Nieto, AO, Rozalem-Aranha, M, Maure-Blesa, L, Rodríguez-Baz, I, Arriola-Infante, JE, Franquesa-Mullerat, M, Zsadanyi, SE, Vaqué-Alcázar, L, Parra, JA, Zhao, ZL, Arranz, J, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Pertierra, L, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2026; 22(2)DOI:10.1002/alz.71157. PMID:41639041. IF:11.100(Q1/1D).
04/02/2026
Immunological Biomarkers to Assess Activity and Treatment Response in IgG4-Related Disease
Moya-Alvarado, P, Lopez-Gomez, M, Martínez-Martinez, L, Park, HS, Leyva, TF, Martín, MC, Codes-Mendez, H, Lacruz, AC, Calleja, S, Magallares, B, Castellví, I, Barros-Membrilla, AJ, Bernárdez, J, Corominas, H. Immunological Biomarkers to Assess Activity and Treatment Response in IgG4-Related Disease. Medicina-Lithuania. 2026; 62(2)DOI:10.3390/medicina62020323. PMID:41752722. IF:2.400(Q1/3D).
01/02/2026
The 4A classification for prognostic stratification of patients with tricuspid regurgitation. A multicenter study
González-Gómez, A, Ruiz, JMM, Bolumburu, AA, Mahia, P, David, EP, García-Moreno, LG, Sitges, M, Li, CH, Alonso, D, Chinchilla, FC, de la Hera, JM, Martin, AG, Hinojar, R, Fernández-Golfín, C, Zamorano, JL. The 4A classification for prognostic stratification of patients with tricuspid regurgitation. A multicenter study. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2026; 444DOI:10.1016/j.ijcard.2025.133977. PMID:41135775. IF:3.200(Q2/3D).
01/02/2026
Intermediate cardiac care units: rationale, resources, and admission criteria. Position statement of the SEC-ACICAC
Viana-Tejedor, A, Losas, PM, Andrea-Riba, R, Corbí-Pascual, M, Rosillo, S, Alonso, JJ, Sionís, A, Pastor, P, Jorge-Pérez, P, García-García, C. Intermediate cardiac care units: rationale, resources, and admission criteria. Position statement of the SEC-ACICAC. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(2)DOI:10.1016/j.rec.2025.10.004. PMID:41130289. IF:4.900(Q1/2D).
01/02/2026
Infectious complications in acquired hemophilia A: insights from the Spanish registry (AHASR)
Mingot-Castellano, ME, Pardos-Gea, J, Rico, AM, Alcalde-Mellado, P, Salvadores-Alvares, V, Jimenes, AJ, Hirnyk, MC, Gutierrez, AB, Bastida, JM, Alén, J, Candel, FG, Penella, DT, Quintana, AM, Navarro, GAM, Palmer, ER, Expósito, MC, Correa, SA, Miñana, LT, Garcia, JAR, Alvarez-Roman, MT, Garcia, RL, Gonzalez, RR, Antoran, JMM, Escobar, NA, Culebras, RA, Badás, MPM, Antonio, SM, Barrientos, MU, Mosteirin, NF, Sanchez, MP, Herrero, SV, Santiago, CC, Miranda, ISC, Mañas, MAP, Fernandez, IV, Izquierdo, CP, Lopez, SC, Vera, PM. Infectious complications in acquired hemophilia A: insights from the Spanish registry (AHASR). HAEMATOLOGICA. 2026; 111(2)DOI:10.3324/haematol.2025.288480. PMID:40820842. IF:10.100(Q1/2D).
01/02/2026
Antithrombotics drugs in Gastrointestinal Endoscopy. Position Statment of the Catalan Society of Gastroenterology
Pons, FR, Vilalta, N, Ibáñez-Sanz, G, Quintana-Carbó, S, Calvo, A, Uchima, H, García-Iglesias, P, Romero-Mascarell, C, Vallès, E, Alvarez, MA. Antithrombotics drugs in Gastrointestinal Endoscopy. Position Statment of the Catalan Society of Gastroenterology. Gastroenterologia y Hepatologia. 2026; 49(2)DOI:10.1016/j.gastrohep.2025.502536. PMID:40803483. IF:1.900(Q3/7D).
01/02/2026
Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease
Llena-Meler, M, Canfran-Duque, A, Madrigal-Matute, J, Rotllan, N. Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. SEMINARS IN CANCER BIOLOGY. 2026; 119DOI:10.1016/j.semcancer.2026.01.003. PMID:41520912. IF:15.700(Q1/1D).
01/02/2026
Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort
Téllez, L, Donate, J, Guerrero, A, Beraza, IA, San Martín, D, Alvarado, E, Echevarria, V, Puente, A, Zamora, J, Del Prado, S, Tenes, A, Balagué, G, Vidal, B, Geli, C, Rodriguez-Gandia, MA, Baiges, A, Brujats, A, Rodríguez, DLH, Sánchez, SFG, Fortea, JI, del Cerro, MJ, Villanueva, C, Garcia-Pagán, JC, Giráldez, A, Albillos, A. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort. JOURNAL OF HEPATOLOGY. 2026; 84(2)DOI:10.1016/j.jhep.2025.09.011. PMID:41076090. IF:33.000(Q1/1D).
01/02/2026
Predictors of early immunosuppression at ulcerative colitis onset in the biological era
Piñero, G, Castillo, E, González-Muñoza, C, Calm, A, Pujol, C, Gordillo, J, Calafat, M, Bertoletti, F, Garcia-Planella, E, Mañosa, M, Domènech, E. Predictors of early immunosuppression at ulcerative colitis onset in the biological era. Gastroenterologia y Hepatologia. 2026; 49(2)DOI:10.1016/j.gastrohep.2025.502533. PMID:40680924. IF:1.900(Q3/7D).
01/02/2026
Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study
Pérez, MAC, Grillo, S, Rombauts, A, Martinez, MAR, Falcó-Roget, A, Albasanz-Puig, A, Viñado-Pérez, B, Fernández-Hidalgo, N, Camps-Relats, L, Bergas, A, Laporte-Amargos, J, López-Contreras, J, Escolà-Vergé, L. Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2026; 67(2)DOI:10.1016/j.ijantimicag.2025.107706. PMID:41456670. IF:4.600(Q1/2D).
01/02/2026
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry
López-López, C, de Castro, EM, Montes, AF, Orozco, EJ, Peraita, SL, Vera, R, Cerdá, P, Calvo, M, Paredes, BG, de Mena, ML, La Casta, A, Gallego, J, Adeva, J, Cano, JMC, Ruiz-Casado, A, Vidal-Tocino, R, García-García, T, Pazo-Cid, R, Garrote, MR, Sastre, J. Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry. Clinical & Translational Oncology. 2026; 28(2)DOI:10.1007/s12094-025-04010-z. PMID:40782167. IF:2.500(Q3/6D).
01/02/2026
Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial
Molassiotis, A, Jordan, K, Karthaus, M, Dranitsaris, G, Roeland, EJ, Schwartzberg, L, Stimamiglio, V, Alonzi, A, Tilola, SO, Bonizzoni, E, Vázquez, EB, Buchler, T, Cheng, Y, Christoph, DC, Alfonso, PG, Lu, X, Majem, M, Mavroudis, D, Syrigos, K, Tomlins, E, Zhou, Z, Zimovjanová, M, Aapro, M. Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial. ANNALS OF ONCOLOGY. 2026; 37(2)DOI:10.1016/j.annonc.2025.10.017. PMID:41110696. IF:65.400(Q1/1D).
01/02/2026
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry
Gonzalez-Cao, M, Berciano-Guerrero, MA, Muñoz-Couselo, E, Manzano, JL, Cerezuela-Fuentes, P, Crespo, G, Soria, A, de Miguel, PA, Sanz, LG, de la Rosa, CA, Castaño, AG, Puértolas, T, Espinosa, E, Medina, J, Bellido, L, Berrocal, A, Majem, M, Castro, RL, Fernandez, LA, Garcia, F, de la Borbolla, MR, Algarra, SM, Márquez-Rodas, I. Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry. Clinical & Translational Oncology. 2026; 28(2)DOI:10.1007/s12094-025-04018-5. PMID:40841506. IF:2.500(Q3/6D).
01/02/2026
Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates
Rueda, A, Garcia-Leon, A, Arena, LA, Mendoza, JI, Avino, A, Fabrega, C, Eritja, R, Paez, D, Alba-Castellon, L, Vazquez, E, Villaverde, A, Mangues, R, Casanova, I, Unzueta, U. Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates. Materials Today Bio. 2026; 36DOI:10.1016/j.mtbio.2025.102698. PMID:41560806. IF:10.200(Q1/1D).
01/02/2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study
Hernández-Sánchez, A, Ramiro, AV, Sträng, E, Turki, AT, Abáigar, M, Versluis, J, Thomas, I, Sobas, M, Elicegui, JM, Castellani, G, Benner, A, Azibeiro, R, Tettero, JM, Mecklenbrauck, R, Martínez-López, J, Pratcorona, M, Mills, KI, Sanz, G, Voso, MT, Sören, L, Röllig, C, Thiede, C, Metzeler, KH, Döhner, K, Heuser, M, Haferlach, T, Valk, PJM, Russell, N, Hernández-Rivas, JM, Huntly, B, Ossenkoppele, G, Döhner, H, Bullinger, L. Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study. LEUKEMIA. 2026; 40(2)DOI:10.1038/s41375-025-02851-9. PMID:41535568. IF:13.400(Q1/1D).
01/02/2026
Challenges in myasthenia gravis diagnosis: an analysis of the diagnostic process of myasthenia gravis in a specialized clinic
Vesperinas, A, Rocaspana-Codana, J, Reyes-Leiva, D, Caballero-Avila, M, Carbayo, A, Collet-Vidiella, R, Llanso, L, Gallardo, E, Turon-Sans, J, Rojas-Garcia, R, Cortes-Vicente, E. Challenges in myasthenia gravis diagnosis: an analysis of the diagnostic process of myasthenia gravis in a specialized clinic. NEUROMUSCULAR DISORDERS. 2026; 59DOI:10.1016/j.nmd.2025.106284. PMID:41442860. IF:2.800(Q2/5D).
01/02/2026
Psychotropic Drugs: A Practical Guide for Use in Dermatology
Carmona-Rocha, E, De Diego-Adeliño, J, Tribó, MJ, Puig, L. Psychotropic Drugs: A Practical Guide for Use in Dermatology. Actas Dermo-Sifiliograficas. 2026; 117(2)DOI:10.1016/j.ad.2025.104518. PMID:41352592. IF:(Q/D).
01/02/2026
Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register-based study
Hamina, A, Pinzón-Espinosa, J, Taipale, H, Schneider-Thoma, J, Radua, J, Efthimiou, O, Cardoner, N, Correll, CU, Fusar-Poli, P, Mittendorfer-Rutz, E, Penninx, BWJH, Ruhe, HG, Tanskanen, A, Vinkers, CH, Leucht, S, Vieta, E, Cipriani, A, Tiihonen, J, Luykx, JJ. Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register-based study. World Psychiatry. 2026; 25(1)DOI:10.1002/wps.70013. PMID:41536102. IF:65.800(Q1/1D).